Cardiovascular events in statin recipients: Impact of adherence to treatment in a 3-year record linkage study

European Journal of Clinical Pharmacology

Volumn 67, Issue 4, 2011, Pages 407-414

  Poluzzi, Elisabetta ^a   Piccinni, Carlo ^a   Carta, Paolo ^a   Puccini, Aurora ^b   Lanzoni, Monica ^b   Motola, Domenico ^a   Vaccheri, Alberto ^a   De Ponti, Fabrizio ^a   Montanaro, Nicola ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Reg Hlth Care Agy Emilia Romagna   (Italy)

Author keywords

Cardiovascular disease; General practice; Medical record linkage; Medication adherence; Statins

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN;

ADULT; ANGINA PECTORIS; ARTHROPATHY; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERIPHERAL ARTHROPATHY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CORONARY DISEASE; DATA COLLECTION; DATABASES, FACTUAL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ITALY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK ASSESSMENT; SEX FACTORS; STROKE;

EID: 79954624167     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0958-3     Document Type: Article

References (21)

1. ZJ Zhang Q Cheng GX Jiang OC Marroquin 2010 Statins in prevention of repeat revascularization after percutaneous coronary intervention-a meta-analysis of randomized clinical trials Pharmacol Res 61 316 320 19922797 10.1016/j.phrs.2009.11.004 1:CAS:528:DC%2BC3cXjt1WjtLw%3D
2. J Afilalo G Duque R Steele JW Jukema AJ de Craen MJ Eisenberg 2008 Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis J Am Coll Cardiol 51 37 45 18174034 10.1016/j.jacc.2007.06.063 1:CAS:528:DC%2BD1cXislCrtQ%3D%3D
3. J Abramson JM Wright 2007 Are lipid-lowering guidelines evidence-based? Lancet 20 369 168 169 10.1016/S0140-6736(07)60084-1 (Pubitemid 46107666)
4. S Yusuf E Lonn J Bosch 2009 Lipid lowering for primary prevention Lancet 373 1152 1155 19345816 10.1016/S0140-6736(09)60357-3
5. EJ Mills B Rachlis P Wu PJ Devereaux P Arora D Perri 2008 Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients J Am Coll Cardiol 52 1769 1781 19022156 10.1016/j.jacc.2008.08.039 1:CAS:528:DC%2BD1cXhsVWht7jE
6. MF Muldoon 2009 Trial evidence for statin-based primary prevention remains dubious J Am Coll Cardiol 53 2312 2313 19520264 10.1016/j.jacc.2009.02. 053
7. E Poluzzi P Strahinja M Lanzoni A Vargiu MC Silvani D Motola A Gaddi A Vaccheri N Montanaro 2008 Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy Eur J Clin Pharmacol 64 425 432 18176802 10.1007/s00228-007-0428-8 1:CAS:528: DC%2BD1cXisFCmtrg%3D
8. A Connor C Tomson 2009 Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease? BMJ 339 b2949 10.1136/bmj.b2949.:b2949- 19696089 10.1136/bmj.b2949
9. MA Hlatky 2008 Expanding the orbit of primary prevention-moving beyond JUPITER N Engl J Med 20 359 2280 2282 10.1056/NEJMe0808320
10. JJ Brugts T Yetgin SE Hoeks AM Gotto J Shepherd RG Westendorp AJ de Craen RH Knopp H Nakamura P Ridker R van Domburg JW Deckers 2009 The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ 338 b2376 10.1136/bmj.b2376.:b2376- 19567909 10.1136/bmj.b2376 1:STN:280:DC%2BD1Mvls1CltQ%3D%3D
11. S Perreault L Ellia A Dragomir R Cote L Blais A Berard L Lalonde 2009 Effect of statin adherence on cerebrovascular disease in primary prevention Am J Med 122 647 655 19559167 10.1016/j.amjmed.2009.01.032 1:CAS:528: DC%2BD1MXnslynur4%3D
12. A Dragomir R Cote M White L Lalonde L Blais A Berard S Perreault 2009 Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting Value Health 13 87 94 19695008 10.1111/j.1524-4733.2009.00583.x
13. S Perreault A Dragomir L Blais A Berard L Lalonde M White D Pilon 2009 Impact of better adherence to statin agents in the primary prevention of coronary artery disease Eur J Clin Pharmacol 65 1013 1024 19529927 10.1007/s00228-009-0673-0
14. P Deambrosis G Terrazzani T Walley G Bader P Giusti P Debetto A Chinellato 2009 Benefit of statins in daily practice? A six-year retrospective observational study Pharmacol Res 60 397 401 19573601 10.1016/j.phrs.2009.06.009 1:CAS:528:DC%2BD1MXhtFSnsrrE
15. G Corrao V Conti L Merlino AL Catapano G Mancia 2010 Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy Clin Ther 32 300 310 20206788 10.1016/j.clinthera.2010.02.004
16. BM Psaty 2010 Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys memorial lecture Circulation 121 940 945 20177009 10.1161/CIRCULATIONAHA.109.933705
17. JJ Caro JL Speckman M Salas G Raggio JD Jackson 1999 Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data CMAJ 160 41 46 9934342 1:STN:280:DyaK1M7jtlWjtw%3D%3D (Pubitemid 29054225)
18. V Shalev G Chodick H Silber E Kokia J Jan AD Heymann 2009 Continuation of statin treatment and all-cause mortality: a population-based cohort study Arch Intern Med 169 260 268 19204217 10.1001/archinternmed.2008.552
19. S Suissa 2008 Immeasurable time bias in observational studies of drug effects on mortality Am J Epidemiol 168 329 335 18515793 10.1093/aje/kwn135 (Pubitemid 352019783)
20. JN Rasmussen A Chong DA Alter 2007 Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 177 186 17213401 10.1001/jama.297.2.177 1:CAS:528: DC%2BD2sXksVyisA%3D%3D (Pubitemid 46089734)
21. F Andersohn SN Willich 2009 The healthy adherer effect Arch Intern Med 169 1635 1636 19786686 10.1001/archinternmed.2009.324